Does the False Claims Act Help Fight Fraud?

In her abstract dated December 4, 2016, Elissa Phillip Gentry, a lawyer-economist says, “yes.”  She claims successful False Claims Act settlements against pharmaceutical companies have helped relinquish inappropriate off-label prescriptions. She posits that it is legal initiatives like the False Claims Act, rather than new scientific information, that leads to increased compliance. She states:

These results suggest that FCA suits can help to spread information regarding appropriateness of off-label uses and call into question some of the expectations underlying current off-label regulation.

Nolan Auerbach & White has a long history of representing courageous whistleblowers in healthcare fraud False Claims Act actions against pharmaceutical companies and hospital systems. More information for potential whistleblowers is located on our main website.

Share and Enjoy !

0Shares
0 0